Literature DB >> 23100110

HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.

Micol S Rothman1, Mary T Bessesen.   

Abstract

As the population with HIV continues to age, specialists in HIV care are increasingly encountering chronic health conditions, which now include osteoporosis, osteopenia, and fragility fractures. The pathophysiology of the bone effects of HIV infection is complex and includes traditional risk factors for bone loss as well as specific effects due to the virus itself, chronic inflammation, and HAART. Examining risk factors for low bone density and screening of certain patients is suggested, and consideration should be given to treatment for those considered high risk for fracture.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100110     DOI: 10.1007/s11914-012-0125-0

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  37 in total

1.  Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.

Authors:  Rein Jan Piso; Madeleine Rothen; Jean Pierre Rothen; Matthias Stahl
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04       Impact factor: 3.731

2.  Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women.

Authors:  M T Yin; R Modarresi; E Shane; F Santiago; D C Ferris; D J McMahon; C A Zhang; S Cremers; J Laurence
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

3.  Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy.

Authors:  Adrian Curran; Esteban Martinez; Maria Saumoy; Luis del Rio; Manuel Crespo; Maria Larrousse; Daniel Podzamczer; Joaquin Burgos; Montse Lonca; Pere Domingo; Jose Maria Gatell; Esteban Ribera
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

4.  The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture.

Authors:  Jessica Pepe; Andrea M Isidori; Mario Falciano; Giancarlo Iaiani; Alessandra Salotti; Daniele Diacinti; Romano Del Fiacco; Emilia Sbardella; Cristiana Cipriani; Sara Piemonte; Elisabetta Romagnoli; Andrea Lenzi; Salvatore Minisola
Journal:  Clin Endocrinol (Oxf)       Date:  2012-11       Impact factor: 3.478

5.  Therapeutic options for low bone mineral density in HIV-infected subjects.

Authors:  Aoife G Cotter; Patrick W G Mallon
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

6.  Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Authors:  Todd T Brown; Allison C Ross; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  Antivir Ther       Date:  2011

7.  Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.

Authors:  Michael T Yin; Chiyuan A Zhang; Donald J McMahon; David C Ferris; Dinaz Irani; Ivelisse Colon; Serge Cremers; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

8.  A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis.

Authors:  Jeannie Huang; Linda Meixner; Susan Fernandez; J Allen McCutchan
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

9.  Continuous antiretroviral therapy decreases bone mineral density.

Authors:  Birgit Grund; Grace Peng; Cynthia L Gibert; Jennifer F Hoy; Rachel L Isaksson; Judith C Shlay; Esteban Martinez; Peter Reiss; Fehmida Visnegarwala; Andrew D Carr
Journal:  AIDS       Date:  2009-07-31       Impact factor: 4.177

10.  Premature decline of serum total testosterone in HIV-infected men in the HAART-era.

Authors:  Vincenzo Rochira; Lucia Zirilli; Gabriella Orlando; Daniele Santi; Giulia Brigante; Chiara Diazzi; Federica Carli; Cesare Carani; Giovanni Guaraldi
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

View more
  10 in total

1.  Relationships Between Physical Activity and Bone Density in People Living with HIV: Results from the SATURN-HIV Study.

Authors:  Joseph D Perazzo; Allison R Webel; S M Khurshid Alam; Abdus Sattar; Grace A McComsey
Journal:  J Assoc Nurses AIDS Care       Date:  2018-03-28       Impact factor: 1.354

2.  [Interference immune system and bone repair].

Authors:  A Serra; H-D Chang
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 3.  Osteoporosis in Human Immunodeficiency Virus Patients - An Emerging Clinical Concern.

Authors:  Filippo Maffezzoni; Teresa Porcelli; Ioannis Karamouzis; Eugenia Quiros-Roldan; Francesco Castelli; Gherardo Mazziotti; Andrea Giustina
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Association of Blood Biomarkers of Bone Turnover in HIV-1 Infected Individuals Receiving Anti-Retroviral Therapy (ART).

Authors:  Najib Aziz; Anthony W Butch; Joshua J Quint; Roger Detels
Journal:  J AIDS Clin Res       Date:  2014

5.  Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.

Authors:  Kristine M Erlandson; Maryann OʼRiordan; Danielle Labbato; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

6.  Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK.

Authors:  Sean J Iwamoto; Micol S Rothman; Shenghui Duan; Jonathan C Baker; Steven Mumm; Michael P Whyte
Journal:  Bone       Date:  2020-01-08       Impact factor: 4.398

7.  Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length.

Authors:  Shirin Kalyan; Neora Pick; Alice Mai; Melanie C M Murray; Kristen Kidson; Jackson Chu; Arianne Y K Albert; Hélène C F Côté; Evelyn J Maan; Azita Goshtasebi; Deborah M Money; Jerilynn C Prior
Journal:  Int J Environ Res Public Health       Date:  2018-05-18       Impact factor: 3.390

8.  Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans.

Authors:  Joel A Dave; Karen Cohen; Lisa K Micklesfield; Gary Maartens; Naomi S Levitt
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

9.  Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort.

Authors:  Emanuele Focà; Paola Magro; Giovanni Guaraldi; Agostino Riva; Anna Maria Cattelan; Giuseppe Vittorio De Socio; Cecilia Costa; Stefania Piconi; Benedetto Maurizio Celesia; Silvia Nozza; Giancarlo Orofino; Antonella Castagna; Giovanni Di Perri; Francesco Castelli; Andrea Calcagno
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

Review 10.  Human immunodeficiency virus in total hip arthroplasty.

Authors:  Jurek Rafal Tomasz Pietrzak; Zia Maharaj; Lipalo Mokete; Nkhodiseni Sikhauli
Journal:  EFORT Open Rev       Date:  2020-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.